Sales decline 12.98% to Rs 31.98 crore
Net profit of Jenburkt Pharmaceuticals declined 42.43% to Rs 5.74 crore in the quarter ended September 2018 as against Rs 9.97 crore during the previous quarter ended September 2017. Sales declined 12.98% to Rs 31.98 crore in the quarter ended September 2018 as against Rs 36.75 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales31.9836.75 -13 OPM %22.1433.74 -PBDT7.8913.25 -40 PBT7.5612.87 -41 NP5.749.97 -42Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)